Intestinal mucus barrier: A potential therapeutic target for IBD

Area of Science:

• Gastroenterology
• Immunology
• Microbiology

Background:

• Intestinal mucus, composed mainly of mucin2 (MUC2), forms the primary protective barrier of the intestinal tract.
• The colonic mucus layer differs from the small intestine, featuring distinct inner (sterile) and outer (colonized) layers.
• Factors like microbes, diet, and immune responses significantly influence mucus layer integrity.

Purpose of the Study:

• To review the critical role of the intestinal mucus barrier in the pathogenesis of inflammatory bowel disease (IBD).
• To highlight therapeutic strategies targeting the mucus barrier for IBD treatment.

Main Methods:

• Literature review focusing on the composition, function, and alterations of the intestinal mucus layer in IBD.
• Analysis of the relationship between mucus barrier dysfunction and IBD development.
• Examination of current and emerging therapies for IBD that aim to repair the mucus barrier.

Main Results:

• Loss of goblet cells and altered mucus composition are characteristic of the colonic mucus layer in IBD patients.
• Mucus barrier damage facilitates microbial access to the intestinal epithelium, potentially triggering inflammation.
• Various therapies, including herbal treatments, show potential for IBD management by restoring mucus barrier function.

Conclusions:

• The intestinal mucus barrier plays a pivotal role in maintaining gut health and is significantly implicated in IBD pathogenesis.
• Therapeutic interventions aimed at repairing or strengthening the mucus barrier represent a promising approach for managing IBD.